Tebufenozide

CAS No. 112410-23-8

Tebufenozide( —— )

Catalog No. M23317 CAS No. 112410-23-8

Tebufenozide is a novel nonsteroidal ecdysone agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 In Stock
50MG 58 In Stock
100MG 87 In Stock
200MG 129 In Stock
500MG 214 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tebufenozide
  • Note
    Research use only, not for human use.
  • Brief Description
    Tebufenozide is a novel nonsteroidal ecdysone agonist.
  • Description
    Tebufenozide is a novel nonsteroidal ecdysone agonist. It shows good efficacy and playing an increasingly important role in the control of Lepidopteran pests.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112410-23-8
  • Formula Weight
    352.48
  • Molecular Formula
    C22H28N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (354.64 mM; Need ultrasonic)
  • SMILES
    CCc(cc1)ccc1C(NN(C(C)(C)C)C(c1cc(C)cc(C)c1)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yun-Sik L , Sung-Eun L , Jino S , et al. Toxicity effects and biomarkers of tebufenozide exposure in Yuukianura szeptyckii (Collembola: Neanuridae)[J]. Environmental Geochemistry & Health, 2018:1-12.
molnova catalog
related products
  • Talampanel

    Talampanel is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity.

  • Protein kinase inhib...

    Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.

  • CDK8-IN-13

    CDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity. CDK8-IN-13 induces apoptosis and reduces the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 exhibits anti-tumour activity.